Axiora Medical
Axiora Medical
Advanced OEM/ODM implant solutions engineered for high performance, primary joint stability, and seamless surgical outcomes in Brazilian orthopedic centers.
Bridging high-volume production capabilities with the specific regulatory and commercial frameworks of the Brazilian orthopedic sector.
A comprehensive analysis of current trends, regulatory environments, clinical preferences, and manufacturing excellence serving Brazil's Unified Health System (SUS) and private supplementary sectors.
The orthopedic implant sector in Brazil represents one of the fastest-growing medical device markets in Latin America. Driven by an aging demographic, rising obesity rates, and the expansion of the public healthcare sector (Sistema Único de Saúde - SUS), the demand for Total Hip Replacement (THR) and Total Knee Replacement (TKR) systems is undergoing unprecedented structural growth. In Brazil, approximately 70-75% of orthopedic reconstruction surgeries are executed within the public health network, putting extreme pressure on hospitals and purchasing consortia to secure high-quality implants at highly competitive prices.
Strategic Market Insight: Success in the Brazilian market requires orthopedic distributors and manufacturing partners to align their production cost-structures with the regional tenders, whilst satisfying the rigorous mechanical and quality standards dictated by ANVISA.
For private sector clinics (Saúde Suplementar), clinical preferences lean towards state-of-the-art biological fixation systems, including advanced 3D-printed porous titanium cups, dual-mobility hip interfaces, and cruciate-retaining or posterior-stabilized knee implants featuring highly cross-linked polyethylene inserts (XLPE) blended with Vitamin E to mitigate long-term wear debris and subsequent osteolysis.
Entering the Brazilian market requires a deep understanding of the regulatory framework managed by the Agência Nacional de Vigilância Sanitária (ANVISA). Total Hip and Knee replacement systems are classified as Class III (High Risk) / Class IV (Maximum Risk) medical devices under Brazilian guidelines.
Under the landmark resolution RDC 751/2022, manufacturers must compile extensive technical dossiers demonstrating mechanical integrity under high-cycle loading regimes (ISO 7206 series for hips, and ISO 14243 series for knee wear-testing). Additionally, overseas factories must undergo periodic audits or demonstrate conformance to receive the Brazilian Good Manufacturing Practices (BGMP) certificate, which mirrors ISO 13485 but incorporates unique administrative steps. Our advanced facilities are structurally prepared to support local Brazilian registration holders (Importadores) by providing comprehensive technical documentation, raw material certificates (ISO 5832-3 Titanium, ISO 5832-12 CoCrMo), and fully-mapped biocompatibility studies.
The global orthopedic reconstruction industry is shifting rapidly towards cementless fixation. Stems and cups utilize plasma-sprayed Titanium coatings combined with Hydroxyapatite (HA) to promote rapid, stable osseointegration. As a leading manufacturer, Axiora utilizes top-tier raw materials:
Transition from standard grit-blasting to plasma-sprayed vacuum titanium coating + Hydroxyapatite (HA) bilayer surfaces to enhance direct secondary bone-anchorage.
Integration of Fourth-Generation BIOLOX® delta Ceramic Heads and Dual-Mobility cups to eliminate hip dislocation risks in older patient demographics.
Production of patient-specific instrumentation (PSI) and navigated surgical trial components compatible with robotic orthopedic surgical consoles.
Ensuring versatile solutions for both primary procedures and complex revisions. Replicable geometric accuracy for optimal fit in diverse patient populations.
An inside look into our 18,600 m² modern facility, combining longitudinal cutting, advanced CNC machining, ultrasonic washing, and rigorous QA.
Axiora Medical Technology (China) Co., Ltd. is a global OEM/ODM powerhouse offering direct factory supply and complete compliance documentation for South American markets.
| Strategic Parameters | Operational Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand Profile | Axiora |
| Established Year | 2017 |
| Factory Infrastructure Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Direct Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection Framework | 100% Finished Product Inspection & Incoming Material Inspection |
| Quality Control Testing Methodologies | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| In-House QA/QC Staff Count | 48 Quality Officers |
| Core Business Type | Orthopedic Medical Device Manufacturer & Exporter (OEM/ODM) |
| Key Regional Markets | Brazil (Latin America), Europe, North America, Middle East, Southeast Asia |
| Global Supply Chain Network | 1,120 Registered Partners |
| Main Customer Types | Medical Device Brands, Importers, Regional Distributors, Hospitals, Government Procurement Projects |
| R&D Capability & Reverse Engineering | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Laser Logo Printing, Private Labeling, Custom Packaging, Mechanical Structural Design, Material Customization, Drawing-Based Manufacturing |
| New Innovations (Past 12 Months) | 126 Newly Released Products/Surgical Tools |
| Dedicated R&D Engineers | 86 Engineers |
Addressing custom clearance challenges, tariff regimes, local warehouses, and hospital sterilization protocols.
Distributing THR and TKR implants in Brazil involves navigating complex custom duties (Imposto de Importação - II) and state-level taxes (ICMS). To assist our partners in Brazil, we offer consolidated container solutions, ensuring complete labeling trace-ability with unique serial numbers conforming to the global UDI (Unique Device Identification) directives. This minimizes administrative delays inside Brazilian customs ports such as Santos or Paranaguá.
The efficiency of a joint replacement procedure is deeply coupled with the reliability of its surgical instrumentation. Axiora supplies ergonomically optimized trial sets, stem inserters, and manual extractors. We offer custom instrument laser marking and anodized coloration coding to help hospital sterilization departments (CME - Central de Material e Esterilização) manage sets quickly and error-free.
Everything you need to know about our sourcing, regulatory support, and clinical alignment for the Brazilian market.
A comprehensive overview of our joint replacement lines designed to restore mobility and alleviate chronic pain.
Partner with a quality-first medical device manufacturer. Get absolute support on technical portfolios, pricing configurations, and ANVISA compliance dossiers.
Send Inquiry Now
